To evaluate the impact of the device learning curve on the outcomes of PROTECT II trial , comparing Impella 2.5 versus the intra-aortic balloon pump ( IABP ) during high-risk percutaneous coronary intervention , we report on a prespecified analysis , excluding the first Impella 2.5 and IABP patients at each site .